Publications Office of the EU
CT2303/2023 - Tender for the supply of Magnesium Sulfate 20 percent for IV Use - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

CT2303/2023 - Tender for the supply of Magnesium Sulfate 20 percent for IV Use

Overview
  • Canceled
    23/03/2026
  • Today
    18/09/2026
Status
Canceled
Type of contract
Supplies
Subject for Renewal
No
Buyer
Department of Contracts
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: MT001 Malta
Business sector (Main CPV)
33690000 Various medicinal products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
The procedure is closed
Procedure details
Tender reference number
Not available
Description

CT2303/2023 - Tender for the supply of Magnesium Sulfate 20 percent for IV Use

Submission Method
Not available
Tenders may be submitted
Not available
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
MT Malta
MT001 Malta
CPV code

33690000 - Various medicinal products

Award method
Criterion:
Type: price
Description: Cheapest
Weight (percentage, exact): 0
Estimated value
Not available
Final contracted value
The procedure is closed
Award of contract
The procedure is closed
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.